Ubhar Capital reviews Jamjoom Pharma Q4 results, maintains TP

12:06 PM (Mecca time) Argaam

Ubhar Capital said Jamjoom Pharmaceuticals Factory Co.'s (Jamjoom Pharma) net profit of SAR 68.07 million in Q4 2025 exceeded its estimate o

To Access this Content, Please Login Or Register

To Access this Content, Please Login or Subscribe

Most Read